"Particularly in small blood vessels that are prone to effects of inflammation and disease in patients with obesity." GLP-1s are also referred to as incretin analogues
Large cardiovascular outcome trials have also demonstrated that several GLP-1 agents reduce major adverse cardiovascular events
Common side effects include nausea, diarrhea, and constipation, usually mild and transient
thats normal inflammation.) But excessive chronic inflammation, which results from an immune system over-policing threats throughout the body, is a leading cause of organ damage, stroke, and neurological problems
Pancreatitis is a rare but serious adverse event reported with GLP-1 agonists
Get up slowly, sit before you stand, and have something you can hold on to nearby